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Abstract
Background: Four genes designated as PTPRK (PTPκ), PTPRL/U (PCP-2), PTPRM (PTPµ) and
PTPRT (PTPρ) code for a subfamily (type R2B) of receptor protein tyrosine phosphatases (RPTPs)
uniquely characterized by the presence of an N-terminal MAM domain. These transmembrane
molecules have been implicated in homophilic cell adhesion. In the human, the PTPRK gene is
located on chromosome 6, PTPRL/U on 1, PTPRM on 18 and PTPRT on 20. In the mouse, the four
genes ptprk,  ptprl, ptprm and ptprt are located in syntenic regions of chromosomes 10, 4, 17 and 2,
respectively.
Results: The genomic organization of murine R2B RPTP genes is described. The four genes varied
greatly in size ranging from ~64 kb to ~1 Mb, primarily due to proportional differences in intron
lengths. Although there were also minor variations in exon length, the number of exons and the
phases of exon/intron junctions were highly conserved. In situ hybridization with digoxigenin-
labeled cRNA probes was used to localize each of the four R2B transcripts to specific cell types
within the murine central nervous system. Phylogenetic analysis of complete sequences indicated
that PTPρ and PTPµ were most closely related, followed by PTPκ. The most distant family member
was PCP-2. Alignment of RPTP polypeptide sequences predicted putative alternatively spliced
exons. PCR experiments revealed that five of these exons were alternatively spliced, and that each
of the four phosphatases incorporated them differently. The greatest variability in genomic
organization and the majority of alternatively spliced exons were observed in the juxtamembrane
domain, a region critical for the regulation of signal transduction.
Conclusions: Comparison of the four R2B RPTP genes revealed virtually identical principles of
genomic organization, despite great disparities in gene size due to variations in intron length.
Although subtle differences in exon length were also observed, it is likely that functional differences
among these genes arise from the specific combinations of exons generated by alternative splicing.
Published: 11 February 2004
BMC Genomics 2004, 5:14
Received: 17 November 2003
Accepted: 11 February 2004
This article is available from: http://www.biomedcentral.com/1471-2164/5/14
© 2004 Besco et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all 
media for any purpose, provided this notice is preserved along with the article's original URL.BMC Genomics 2004, 5 http://www.biomedcentral.com/1471-2164/5/14
Page 2 of 19
(page number not for citation purposes)
Background
Over the past decade, receptor protein tyrosine phos-
phatases (RPTPs) have emerged as integral components of
signal transduction in the vertebrate and invertebrate
central nervous system. RPTP domain structure suggests
cell adhesive properties, and studies on Drosophila
mutants have provided strong evidence that specific
RPTPs act together to provide a set of partially redundant
signals necessary for muscle targeting and fasciculation
decisions in CNS neurons [1,2], both crucial components
in the establishment and maintenance of neural circuits.
RPTPs have been divided into eight major subfamilies
(Figure 1), based on phylogenetic analysis of the phos-
phatase domains [3]. Four of these subfamilies (R2A, R2B,
R3, and R4) play critical roles in CNS development [4].
Common to all Type 2 RPTPs is an extracellular segment
containing a combination of multiple fibronectin and
immunoglobulin (Ig)-like domains, and a single trans-
membrane region. The intracellular region contains a
membrane proximal juxtamembrane domain, followed
by a catalytically active tyrosine phosphatase domain and
a second inactive domain. Type 2 RPTPs have been further
subdivided into two distinct classes (R2A and R2B). Genes
in the R2B class are differentiated from the R2A class by an
additional MAM (Meprin/ A5/PTP mu) domain at the N-
terminus [5]. In addition to a putative role in signal trans-
duction, R2B molecules have cell adhesive properties [6].
Because no invertebrate homologues of the four R2B mol-
ecules have been found to date [7], and no ESTs indicative
of R2Bs have been isolated from invertebrates, the
function(s) of these phosphatases is likely to be highly
specific to vertebrate species.
Previously, we have described the genomic structure of
human PTPρ [8] and have shown that the transcript is
Classification of receptor-like protein tyrosine phosphatases (RPTPs) into eight subfamilies (R1-R8), based on sequence similar- ity among PTP catalytic domains [3] Figure 1
Classification of receptor-like protein tyrosine phosphatases (RPTPs) into eight subfamilies (R1-R8), based on sequence similar-
ity among PTP catalytic domains [3]. PTPµ, κ, ρ and PCP-2 are members of the R2B subfamily.
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expressed primarily in the central nervous system where it
delineates a distinct developmental compartment in the
cerebellar cortex [9,10]. In the present study, the genomic
structures of all four murine R2B genes (PTPκ, PTPµ, PTPρ
and PCP-2) were compared, and their expression local-
ized to specific cell types within the central nervous sys-
tem. The 5'-genomic sequences were examined for
putative promoter regions and transcription factor bind-
ing sites, and full-length sequences were used to deter-
mine the phylogenetic relationship between the four
genes. Clustal-X alignment of cDNA and Genbank
sequences predicted the presence of alternatively spliced
exons. Five such exons were confirmed experimentally,
with the majority being localized in the juxtamembrane
and first phosphatase domain in each of the four genes.
Results and Discussion
Murine R2B gene size and exon/intron organization
The chromosomal localization of the R2B genes has been
determined in several vertebrate species: In the human,
the PTPRK gene is located on chromosome 6, PTPRL/U on
1, PTPRM on 18 and PTPRT on 20. In the rat, PTPRK
(NW_047547; incomplete) is located on chromosome 1,
PTPRL (NW_047724) on 5, PTPRM (NM_047819) on 9,
and PTPRT (MN_47659) on 3. The four murine R2B genes
(ptprk/PTPκ, ptprl/PCP-2, ptprm/PTPµ, and ptprt/PTPρ) are
located on mouse chromosomes 10, 4, 17, and 2,
respectively.
Murine and human R2B cDNA sequences were used to
identify the corresponding genomic DNA contigs in the
Celera and NCBI genomic databases, using BLAST and
MEGABLAST programs. Alignments were used to estab-
lish exon and intron size, and junction phase. The
genomic structure of human PTPρ has been reported pre-
viously [8]; the human PTPµ,  κ and PCP-2 annotated
structures are available from the authors (rot-
ter.1@osu.edu) upon request. The sizes and genomic
organization of the mouse R2B genes are derived from
Figures 2, 3, 4, 5, and are summarized in Figure 6. The
overall size of the mouse genes and their corresponding
human orthologs was very similar. In general, gene size
exceeded the average, especially in the case of PTPρ, which
was the largest gene (~1,117,873 bp), followed by PTPµ
(~686,308 bp), PTPκ (~521,813 bp) and PCP-2 (~63,884
bp) (Figure 6). The recent completion of the human chro-
mosome 20 sequence [11] revealed that PTPρ is the largest
confirmed gene on that chromosome, due primarily to
expanded introns in the genomic region containing cod-
ing regions for the extracellular and juxtamembrane seg-
ments of the protein. Although the functional
consequence of this large gene size is not clear, one pre-
dicted outcome is an extended time period for transcrip-
tion of the corresponding mRNA.
Each of the R2B genes contained over 30 exons, which
were examined pairwise to determine the overall nucleo-
tide/exon identity between the four genes (Figure 7).
Three major regions were delineated, each with varying
degrees of sequence identity: Exons 2–13 comprised the
extracellular segment (MAM, Ig and four fibronectin (FN)
type III domains), exon 14–18 (juxtamembrane region),
and exons 19–32 (two phosphatase domains). Although
the number of exons comprising each of the extracellular
domains was identical in each of the four genes, exon size
varied in some domains and remained unchanged in oth-
ers. Within the extracellular segment, the MAM domain
showed the most extensive variation in exon size: The first
exon ranged from 123 to 132 bp, and the third from 79 to
82bp (Figure 8). MAM domains are comprised of 160–
170 amino acids containing four conserved cysteines;
their function has been examined in some detail. When
expressed in non-adherent cells, PTPµ [12-14] and PTPκ
[15] proteins formed large calcium-independent clusters.
Aggregation was strictly homophilic, consisting exclu-
sively of cells expressing only a single R2B type [14-16].
Because this property had not been demonstrated with
any of the other RPTP subfamilies, a crucial role for the
MAM domain in this homophilic interaction was implied.
However, in an in vitro binding assay in which regions of
recombinant PTPµ were expressed [17], the homophilic
binding site was localized to the immunoglobulin (Ig)-
like domain. Subsequently, MAM and Ig domains were
shown to function cooperatively in homophilic binding
in both PTPµ and PTPκ [16]. It was suggested that the
binding site is located in the Ig domain and the MAM
domain is part of a "sorting" mechanism that confers
homophilic binding specificity [6]. Figures 7 and 8 show
that, when combined with the invariant 272 bp middle
exon, each R2B MAM domain had a unique combination
of exon sizes and low sequence identity, indicating a
region of high specificity. The adjacent Ig-like domain
contained exons of identical size, implying a less specific
role than that of the MAM domain. These marked varia-
tions in sequence identity are consistent with the idea that
the MAM domain plays a role in the mediation of
homophilic binding specificity [6].
The four FN type III repeats are involved in general adhe-
sive interactions. The size of the first and third of these
domains was identical among the R2B genes, whereas the
second and fourth FNIII domains differed slightly (Figure
8). In the second FNIII domain, exon sizes varied from
297 in ptprt, to 303 in ptprk, and 309 in ptprm and ptprl.
The only difference in the fourth FNIII domain was in
ptprk, in which one of the three exons comprising this
domain was slightly larger (106 vs 103) than in the other
three genes.BMC Genomics 2004, 5 http://www.biomedcentral.com/1471-2164/5/14
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Organization of the murine PTPρ gene based on Celera genomic sequences Figure 2
Organization of the murine PTPρ gene based on Celera genomic sequences. Left to right: Exon number, 3' splice 
site, exon sequence, 5' splice site, nucleotide number, exon size, intron size, intron phases and protein domain are shown. 
Amino acids (standard one letter code) are listed below the encoding nucleotides. D1 and D2 represent the first and second 
phosphatase domains, respectively; a to i designations indicate the individual exons within a single domain.
Genomic sequence of murine PTPρ/ptprt (AF152556)
_________________________________________________________________________________________________________________________________________
exon# 3’ splice site exon sequence 5’ splice site nt # exon sizeintron size phase domain
    (bp)                (bp)
__________________________________________________________________________________________________________________________________________
1 CCTCGCGCCT…. AGC GCC GCA G gtgagtgcg 1-269 269 293844 1  sig pep
     S      A       A    G
2 tttctgtag GT GGC TGT TCT…..GTG CCC ACA G gtatgtgat 270-395 126 85242 1 MAMa
G      C     S          V       P      T   G
3 ggtctccag GG TCC TTC ATG…...TTC TAT CAG gtatgccat 396-667 272 9739 0 MAMb
 S      F     M          F      Y      Q
4 atgttgcag GTG ATA TTT……CAT CCA TGC A gtaagtcta 668-749  82 14141 1  MAMc
 V       I      F            H      P      C   R
5 gtctcttag GA AAA GCA CCT…..TGG CTC CAG gtaagaatg 750-865 116 15049 0 Ig a
 K      A      P         W      L      Q
6 tatatcag       CAA TGG AAT…..ATT GTG AAA G gtgagtacc 866-1040 175 91543 1 Ig b
                Q      W     N          I       V      K    E
7 ttctttcag AG CCT CCC ACG….AAG TGT GCC G gtaaggatg 1041-1334 294 217065 1 FN#1
P      P      T          K      C      A    D
8 attttacag AT CCC GTG CAT….GAA GAG GAT G gtgagtgag 1335-1631 297 26786 1 FN#2
 P       V      H         E       E      D   V
9 ttcagacat TT CCA GGA GCT….CTC TAT GAG gtaaggagg 1632-1741 110 89668 0 FN#3a
 P      G      A          L      Y      E
10 gtcacacag ATT AAC TAC…..AAG ATT TCA G gtatctctt 1742-1943 202 1275 1 FN#3b
 I       N     Y             K      I      S    A
11 ctttcccag CT CCA TCA ATG…..GCC CCA GTC AG gtgaggaac 1944-2046 103 41274 2 FN#4a
 P      S      M          A      P      V   S
12 ttttttcag   T GTT TAC CAG…..GCA AAT GGA gtaagtagg 2047-2320 274 31487 0 FN#4b
              V     Y      Q          A      N      G prot clvg
13 tctccctag GAG ACA AAA….GCT ACA AAA G gtatgttga 2321-2357  37 14502 1 FN#4c
E      T      K          A      T      K    A
14 tgtggtcag CA CCA ATG GGC….CTC ACC ACA G gtgatcatc  57 19979 1
 P      M     G           L       T      T   G
15 ccccgcaag GT GCT TCC ACT….ATC AAA AGG AG gtgagtctc 2358-2493 136 10854 2 Tmb
A      S      T           I       K      R     R
16 aatctatag A AGA AAT GCT…..TCC TAT TAC TT gtaagtatc 2494-2523  30 30765 2 wedge 
  R      N      A         S      Y      Y     L
17 cttgcacat G TCC CAA AGG…..AAT GGA TTC A gtaagtcaa 2524-2681 158 9924 1 wedge
 S      Q      R          N      G     F    T
17a  absent
18 tctttgaag CA GAT GGC AGC.…GAA TAC GAG gtaagagct 2682-2872 191 19697 0 wedge
 D      G       S         E      Y      E
19 gcattgtag GCC TTA CCA……ATC ATA TCT T gtaggtttc 2873-2960  88 11746 1 D1a
 A      L       P            I       I       S   Y
20 tctctacag AT GAC CAC TCT…...TAC ATT GAC gtgagtatc 2961-3037  77 9573 0 D1b
 D      H     S             Y      I       D
20a  absent
21 attatccag GGG TAC CAC……GCA ACC CAA G gtaagtgtc 3038-3074  37  1402 1 D1c
                  G      Y      H             A      T      Q   G
22 tgtcaccag GT CCA ATG CAA……GTG GGC AGG gtaagcctc 3075-3172  98 3433 0 D1d
P      M      Q            V       G      R
22a acctattag CAC CCA GCG….CCC GGA ATG gtaataatg  60   645 0 D1e
  H      P       A          P      G      M
23 cggccacag GTG AAG TGT……GTC CAG AAG gtaagtttc 3173-3289 117 1199 0 D1f
  V      K      C            V      Q      K
24 tctcctcag AAA GGC TAC…..GTC CAT TGC AG gtgagtcaa 3290-3444 155 3272 2 D1g
 K      G      Y          V      H      C      S start cat core
25 ctcttccag      T GCT GGA GCC….CAG ACA GAG gttagtcct 3445-3580 136  1536 0 D1h
  A      G       A         Q      T       E end cat core
26 accttgcag GAG CAG TAC…..GAG TTT CAG gtatggaca 3581-3730 150  1811 0 D1i
 E       Q     Y             E      F     Q
27 cccccacag ACA CTC AAC…..CTG ATG GAT gtaagctga 3731-3904 174  4334 0 D2a
  T      L      N           L      M      D
28 ttttgtcag AGC CAC AAG…..ACT GCT CAG gtaggaggc 3905-4036 132 12637 0 D2b
  S      H      K           T      A      Q
29 ttgcggcag CTC TGT ATG…..ATG GCT CGG gtaagtaca 4037-4162 126   826 0 D2c
  L     C      M          M       A      R
30 tgttctcag CCA CAG GAT….GTC CAC TGC CT gtgagtgct 4163-4326 164 2909 2 D2d
  P     Q       D         V      H      C      L
31 tttgtttaa      A AAT GGG GGA….GAG ACG CTG gtgagcatc 4327-4462 136   869 0 D2e
  N      G      G          E       T      L
32      tcctctcag GAA  CAG  TAT……TCC  TTT  TAG 4463-4516 442 - -
  E     Q       Y            S      F      *BMC Genomics 2004, 5 http://www.biomedcentral.com/1471-2164/5/14
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Organization of the murine PTPµ gene based on Celera genomic sequences Figure 3
Organization of the murine PTPµ gene based on Celera genomic sequences. Left to right: Exon number, 3' splice 
site, exon sequence, 5' splice site, nucleotide number, exon size, intron size, intron phases and protein domain are shown. 
Amino acids (standard one letter code) are listed below the encoding nucleotides. D1 and D2 represent the first and second 
phosphatase domains, respectively; a to i designations indicate the individual exons within a single domain.
Genomic sequence of murine PTPµ/ptprm (NM_008984)
_____________________________________________________________________________________________________________________________________
exon# 3’ splice site exon sequence 5’ splice site nt # exon size intron size phase domain
     (bp) (bp)
_____________________________________________________________________________________________________________________________________
1 CTCAGCACC  ATG AGG ACA …. ACA TTT TCA G gtaagcgag 1-428 73 163557 1 sig pep
  M       R    T             T      F      S   G
2 cccttgtag GT GGC TGC CTC….ATG CCA  TCA G gtttgccct 429-551 123 97536 1 MAMa
G       C      L  M     P       S   G
3 ttcccgcag GC TCC TTC ATG….TTT  TAC  CAG gtacaggct 552-823 272 19682 0 MAMb
 S      F      M          F     Y       Q
4 atttttcag      GTG ATT TTT….CAC CCG TGC A gtaaggctt 824-902 79 12435 1 MAMc
   V      I       F         H      P      C    T
5 cccatgtag CA AGA ACT CCC….TGG CTG CAG gtacgtgtg 903-1018 116 16646 0 Ig a
R      T      P    W     L     Q
6 ctgatacag GGA ATT GAT…GTA GTT AAA G gtatttaat 1019-1193 175 3596 1 Ig b
  G       I       D V    V      K    E
7 tgctttcag   AG CCA CCT GTT…..AAG TGT GCC G gtgagtatc 1194-1487 294 84865 1 FN III #1
P      P       V K    C      A    D
8 aaaaaatag AT CCC ATG CTG …...GAT GAA GAC C gtgagtgct 1488-1796 309 3634 1 FN III #2
P     M      R    D      E      D    L
9 cctctctag TC CCA GGA GCT……TTA TAT GAG gtaacttac 1797-1906 110 8741 0 FN III #3a
P      G       A    L      Y     E
10 cctttgcag        ATC ACC TAC…….AAA ATA TCA G gtatcatac 1907-2108 202 3546 1 FN III #3b
 I       T       Y    K     I      S    A
11 tttccctag CA  CCA TCC ATG…...GCT CCA GTC AG gtaaggggc 2109-2211 103 20179 2 FN III #4a
  P      S      M   A      P       V    S
12 tttatctag    T GTC TAT CAA……GCC AAT GGG gtaagtgtg 2212-2485 274 964 0 FN III #4b
V Y      Q    A      N      G prot clvg
13 ttgatacag     GAA ACC AAA….GCC ACA AAA G gtaggttga 2486-2522 37 29944 1 FN III #4c
   E      T      K   A      T     K    G
14  absent
15 tgtctctag     GG GCC GTT ACT….GCC AAG AAG AG gtaggcttg 2523-2655 133 72797 2 Tmb
  A      V      T   A     K      K    R
16 absent
17 tgtcccaag     G AAG GAG ACG….AAT GGG AGA T gtaagtgcc 2656-2807 152 3286 1 Wedge
  K       E       T  N      G       R   S
17a tctccacag CT GTG TCT TCA….TAT TAC CCA G gtaacgggc 2808-2882 75 4815 1 Wedge
V       S      S       Y     Y      P    D
18 cctttccag AT GAG ACC CAC….GAG TAT GAG gtgagcctg 2883-3070 188 47224 0 Wedge
E       T      H         E  Y      E
19 ctcttccag AGC TTC TTT……ATC ATT GCA T gtaagtggt 3071-3158 88 14951 1 D1a
   S      F     F    I    I      A    Y
20 gtcttgcag AT GAT CAC TCT…..TAC ATC GAT gtacgtatc 3159-3235 77 2344 0 D1b
D      H     S    Y     I      D
20a absent
21 tatccttag GGC TAT CAT……GCA ACC CAA G gtaagttct 3236-3272 37 18809 1 D1c
G     Y      H       A      T      Q   G
22 ttttggcag   GA CCC ATG CAG….GTG GGA AGG gtaagctgg 3273-3370 98 27239 0 D1d
   P     M       Q      V      G      R
22a   absent
23 tccttgcag GTG AAA TGC.…..GTG GAA AAG gtaagtgtg 3371-3487 117 4444 0 D1f
V     K       C      V     E      K
24 ggactacag    AGA GGC ATT…GTA CAC TGC AG gtaaggaga 3488-3642 155 175 2 D1g
R     G       I  V     H   C     S start cat core
25 tctgagcag       T GCT GGA GCA….CAG ACA GAG gtactgaac 3643-3778 136 2894 0 D1h
A      G      A   Q  T      E end cat core
26 cctcttcag GAG CAG TAC….GAA TTC CGG gtaatcggg 3779-3928 150 910 0 D1i
   E      Q      Y    E     F      R
27 atcccacag ACT CTC AAC…..CTA ATG GAC gtaaggcac 3929-4102 174 963 0 D2a
   T      L     N    L     M     D
28 tgtctgcag      AGC TAT AAA…..CCT GCC CAG gtgagtcca 4103-4234 132 2513 0 D2b
S      Y    K    P    A      Q
29 tgggttcag     CTG TGT CCA…..GCC TCC AGA gtaagagcc 4235-4360 126 2081 0 D2c
     L    C      P     A      S      R
30 cctctgcag CCC CAG GAT….GTG CAC TGC TT gtgagtatc 4361-4524 164 5228 2 D2d
P     Q      D   V      H      C     L
31 ctatgacag        G AAC GGA GGA…GAC CTC CTG gtaggatgc 4525-4660 136 10310 0 D2e
  N      G      G   D    L       L
32 cccttccag     GAT CAG TAC…TCG GGC TGA 4661-4802 54
D     Q      Y   S      G      *BMC Genomics 2004, 5 http://www.biomedcentral.com/1471-2164/5/14
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Organization of the murine PTPκ gene based on Celera genomic sequences Figure 4
Organization of the murine PTPκ gene based on Celera genomic sequences. Left to right: Exon number, 3' splice 
site, exon sequence, 5' splice site, nucleotide number, exon size, intron size, intron phases and protein domain. Amino acids 
are listed below the encoding nucleotides. D1 and D2 represent the first and second phosphatase domains, respectively; a to i 
designations indicate the individual exons within a single domain.
Genomic sequence of murine PTPκ/ptprk (NM_008983)
_________________________________________________________________________________________________________________________________________
exon# 3’ splice site exon sequence 5’ splice site nt # exon sizeintron size phase domain
    (bp)      (bp)
__________________________________________________________________________________________________________________________________________
1 ccctcccag AGCAAACTA …..TTC TCA GCA G gtgagaggt  876-1231 356 131486 1 sig pep
- - -        F    S        A    G
2 cctttctag GT GGC TGT ACT ….ATG CCT CAA G gtaagtcac 1232-1354 123  57100 1 MAMa
G       C      T         M      P      Q    G
3 tcatttcag GT TCT TAT ATG…..GAA TAC CAG gtaatcccc 1355-1626 272  70777 0 MAMb
         S      Y     M          E       Y      Q
4 tcatttcag GTA ATA TTT….TAT CCT TGC G gtaggtttt 1627-1708  82   1866 1 MAMc
            V       I      F         Y      P      C   D
5 tttaaaag   AT AAA TCT CCT….TGG CTG CAG gtaaggccc 1709-1824 116  18525 0  Iga
  K      S      P         W      L      Q
6 tgttcacag         AGA CGC AAT….ATT GTG AGA G gtaatacct 1825-1997 175  28441 1  Igb
          R      R     N          I       V      R    E
7 cttttctag   AA CCA CCT AGA….AAG TGT GCA G gtaagctgg 1998-2293 294 81260 1 FN#1
  P      P      R          K      C      A    E
8 ttttgcag   AA CCT ATG CGG….GAT GAA GAT G gtaagctca 2294-2596 303 6837 1 FN#2
  P       M      R         D       E      D   V
9 tgtttctag   TG CCC GGG CCT….CAG TAT GAG gtatgcaaa 2597-2706 110  2027 0 FN#3a
          P      G      P          Q      Y      E
10 ccacaacag GTG AGC TAT….AAT ATC TCA G gtaagcaaa 2707-2908 202  7903 1 FN#3b
    V       S     Y        N      I      S    A
11 tcttttcag   CT CCA AGC TTA….GCT CCT ATC AG gtaaggggg 2909-3014 106 9623 2 FN#4a
          P      S      L          A      P      I   S
12 cccccaaag  T GCT TAT CAA….GTG GAG AAG gtgagatta 3015-3288 274 3721 0 FN#4b
           A     Y      Q          V      E      K prot clvg
13 ctctgccag GAA ACT AAA….GCT ACA AAA G gtaagagac 3289-3325 37 54924 1 FN#4c
  E      T      K          A      T      K    A
14 absent
15 ttcctttag  CA GCA GCA ACA….GTG AAA AAG AG gtaggtctg 3326-3464 139 3015 2 Trans mem
          A     A      T          V       K      K     S
16 gcttcccag    G AGG AGC TAC…TCC TAC TAC CT gtaagtaga  30 5208 2 wedge
R      R      Y         S      Y     Y     L
17 ttttggcag      C AAG CTT GCT….AGT CCA CTT G gtaagttac 3465-3625 161 1943 1 wedge
         K      L      A          S      P     R    L
17a tttccacag    TG CCC AAT GAT….GCC GTG TTA A  gtgaggcct 3626-3661  36 4358 1 wedge
  P     N       D           A      V       L   D
18 atctgccag     AT GAG AAC CAC….GAA TAC GAG gtgaaagct 3662-3846 185 1650 0 wedge
   E      N       H         E      Y      E
19 tcttcccag        AGC TTC TTT….ATT ATC GCA T gtaagcatc 3847-3934  88 1288 1 D1a
          S     F      F         I       I       A   Y
20 ctttcag   AT GAT CAC TCC….TAC ATC GAC gtaagtgtc 3935-4011  77  3396 0 D1b
          D      H     S          Y      I       D
20a ggctgtag ATT TGG CTG TAC AGG GAT gtaagtacc 4012-4029 18 3178 0 D1b2
 I       W      L      Y      R       D
21 ctactttag GGC TAC CAG….GCA ACT CAA G gtaaaattt 4030-4066  37  1416 1 D1c
          G      Y      Q         A      T      Q   G
22 tgtttacag GC CCA GTT CAT….GTT GGC CGG  gtaagagaa 4067-4164 98   675 0 D1d
         P      V      H         V       G      R
22a absent
23 catcactag GTG AAA TGC….TTG GAA AGG gtaagcatt 4165-4281 117 4568 0 D1f
          V      K      C         L      E      R
24 tttgtacag AGG GGC TAT….GTA CAC TGC AG gtgagcaac 4282-4433 155 4689 2 D1g
         R      G      Y          V      H      C      S start cat core
25 atttctcag      T GCT GGT GCT….CAG AGA GAG gtaaactga 4434-4572 136   229 0 D1h
          A      G       A         Q      T       E end cat core
26 ttttgatag        GAA CAG TAC….GAA TTT CAG gtgcagact 4573-4722 150  1542 0 D1i
          E       Q     Y         E      F     Q
27 cctctttag ACT CTG AAT….CTT ATG GAT gtaagagac 4723-4896 174  3906 0 D2a
          T      L      N          L      M      D
28 tttccacag AGC TAT AGG….CTG TCT CAG gttggtaga 4897-5028 132 141 0 D2b
         S      Y      R          L      S      Q
29 cacacctag        GGC TGC CCA….CTA ACG AGA gtaagtctc 5029-5154 126 2690 0 D2c
         G     C      P          L       T      R
30 tctctacag       CCA CAG GAG….ATC CAC TGC TT gtgagtagg 5155-5318 164  507 2 D2d
 P     Q       E         I      H      C L
31 tgctttcag   G AAT GGC GGT….GAA GCC CCG gtgagccac 5319-5454 136 2896 0 D2e
        N      G      G          E       A      P
32 atgatgcag GAG CAG TAT….TCC TCA TAG ttcgctgag 5455-5896 439 -
          E     Q      Y         S      S      *BMC Genomics 2004, 5 http://www.biomedcentral.com/1471-2164/5/14
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Organization of the murine PCP-2 gene based on Celera genomic sequences Figure 5
Organization of the murine PCP-2 gene based on Celera genomic sequences. Left to right: Exon number, 3' and 5' 
splice sites, nucleotide number, exon size, intron size, intron phases and protein domain are shown. Amino acids (standard one 
letter code) are listed below the encoding nucleotides. D1 and D2 represent the first and second phosphatase domains, 
respectively; a to i designations indicate the individual exons within a single domain. **Exon not transcribed in brain.
Genomic sequence of murine PCP-2/ptprl (NM_011214)
_________________________________________________________________________________________________________________________________________
exon# 3’ splice site 5’ splice site nt # exon sizeintron size phase domain
    (bp)      (bp)
_________________________________________________________________________________________________________________________________________
1 gcggcggcc ATG GCC CGG….ACT CCC GCA G gtaagcgcg 258-451 194 14132 1 sig pep
M     A       R          T      P       A    A
2 tcctcacag CT GGC TGC ACC….CTG CCC CAT G gtgagccta 452-583 132  2855 1 MAMa
 G      C       T          L      P      H    G
3 tctctgcag GT GCC TAC TTG….GAG TTT CAG gtgggctgg 584-855 272   444 0 MAMb
A       Y       L          E      F      Q
4  ttccctcag GTG CTG TTT….TAT CCC TGC G gtgagtccc 856-937 82   107 1 MAMc
V       L      F         Y      P       C   A
5 ttcccacag CA AAG GCC CCT….TTC CTG CAG gtgagcgtc 938-1053 116   260 0 Iga
K      A       P         F       L      Q
6 tctcttcag CTG CAG AGT….ATC GTC AAA G gtcagccga 1054-1228 175   443 1 Igb
R     Q      S         I        V      K    E
7 tcgtcgcag AG CCT CCC ACC…AAG TGC GCA G gtgagtggc 1229-1522 294 10273 1 FN#1
 P      P       T         K      C      A   E
8 tgtctccag AG CCC ACG AGG….GAT GAA GAT G gtaagcctg 1523-1831 309  4446 1 FN#2
 P       T      R          D       E      D   V
9 cccttccag TG CCT GGT GGG….CAG TAT GAG gtgaacagg 1832-1941 110   237 0 FN#3a
 P      G      G           Q     Y      E
10 tacccccag ATC AGC TAC….AAC ATC TCA G gtgagcttc 1942-2143 202   314 1 FN#3b
  I       S      Y         N      I       S    A
11 tcttctcag CT CCC AGC TTT….GCC CCC ATC AG gtgagaaag 2144-2246 103  2644 2 FN#4a
P      S      F          A       P       I    S
12 cctgtccag     C GTC TAC CAG...CTG AAA GGG gtgaggggc 2247-2520 274    794 0 FN#4b
           V     Y      Q          L      K      G prot clvg
13 tacttccag GAG ACC CGG….GCC AGG AAA G gtgagtcca  2521-2557  37   722 1 FN#4c
          E      T      R          A      R      K    A
14 absent
15 tctccccag  CT GCG TGC AAG….ATC CGC AAA GG gtgagtggg 2558-2696 139  2864 2 Trans mem
          A      C      K         I       R      K     G
16* ** cgctgccag   G AGG GAC CGC….TCT TAC TAC CC gtgagtagt   30  1287 2 wedge
R     D    R         S     Y      Y     P
17 cttctgcag    G AAG CCA GTG….AGT CCT CGT G gtaagtact 2697-2854 158 1270 1 wedge
         K      P      V          S       P      R    G
17a tatccacag GG ATA ATG AGC….TGT ATA TAC G gtgtatata  75 3607 1 wedge
  I       M     S        C     I      Y   G
18 ttcttgcag GA GAC CAG CGA….GAG TAC GAG gtgggcctg 2855-3045 191   535 0 wedge
 D      Q       R         E      Y      E
19 ctttggcag        AGT TTC TTT….GTG TCT GCC T gtgagttct 3046-3121  76   383 1 D1a
          S      F       F         V      S       A   Y
20 tgttcacag  AT GAT CGA CAC….TAC ATA GAC gtgagtgcc 3122-3198  77 1584 0 D1b
          D      R     H          Y      I       D
20a atcattaag ATT CGG ATA   AAC CGA CAA gtaagtatc  18 4877 0 D1b2
I    R    I      N      R Q
21 ctgtttcag        GGC TAC CAC….GCC ACT CAA G gtacctggc 3199-3235  37   659 1 D1c
          G      Y      H         A      T      Q   G
22 cgcccccag GG CCA AAG CCT….GTG GGC AGG  gtaagcggg 3236-3333  98    18 0 D1d
          P      K      P         V       G      R
22a gctggggag  GGG GGG TTG…GTG  AAC  CCT gtgctctgg  60     18 0 D1d2
   G       G       L        V       N      P
23 gggccccag GTG AAG TGT….CTG GAG CGG gtaagtctc 3334-3450 117  687 0 D1f
         V      K      C         L      E      R
24 tttccacag AGA GGT TAC….ATT CAC TGC AG gtggggaca 3451-3605 155 2116 2 D1g
         R      G      Y          I      H      C      S start cat core
25 tcccctcag             T GCA GGA ACT….CAG ACG GAG gttcggacc 3606-3741 136   429 0 D1h
         A      G       T         Q      T       E end cat core
26 ctgttccag GAA CAA TAT….GAG TTC CAG gtaggggga 3742-3891 150  1625 0 D1i
          E       Q     Y         E      F     Q
27 tctctgcag ACG CTG AAC….CTG ACT GAC gtgagaatc 3892-4065 174  1564 0 D2a
             T      L      N         L      T      D
28 cctctgcag AGC TAC ACA….TCC GCC TGG gtgaggctc 4066-4206 141   933 0 D2b
            S      Y      T        S      A      W
29 gtatcccag CCC TGC TTG….TCT TCT CGG gtgagtgtc 4207-4332 126  124 0 D2c
            P      C       L      S       S      R
30 catcccag  CTG CAG GAG….GTG CAT TGT CT gtgagtgct 4333-4490 158  1280 2 D2d
    L     Q       E         V      H      C L
31 ttcctttag       C AAC GGG GGT….GAG ACC ATG gtgaggagc 4491-4626 136   194 0 D2e
           N      G      G          E       T      M
32 tttcctcag  GAT CAG TAT;….TTG AGA TAG caggcgcct 4627-5732 1107 -
          D      Q      Y          L      R      *BMC Genomics 2004, 5 http://www.biomedcentral.com/1471-2164/5/14
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Within the intracellular segment, the most dramatic vari-
ation in size, number and percentage nucleotide identity
was observed in exons corresponding to the
juxtamembrane region (Figures 7 and 8). This region con-
sisted of six distinct exons (14–18) and is thought to be
involved in substrate recognition and specificity, proper-
ties likely to show the greatest differences among the
RPTPs (discussed below). Sequence comparison and
exon/intron structure indicated that the two phosphatase
domains (exons 19–32) were highly conserved. Further-
more, the degree of nucleotide identity was constrained to
a relatively narrow range. A detailed analysis of the R2B
phosphatase domains has been described previously [8].
The first intron in all four R2B genes (Figure 6) was dis-
proportionately large, a feature shared with other cell
adhesion molecules. Intron/exon junctions (Figures 2, 3,
4, 5) conformed to the AG/GT rule [18]. Precise exon
boundaries were determined by the presence of consensus
splice sites [19] and preservation of the cDNA reading
frame. Exon/intron boundaries were identical in all four
mouse and human genes. Extracellular exons were prima-
rily in phase 1 and the boundaries of the protein domains
were always demarcated by a phase 1 boundary. In con-
trast, intracellular exons were much smaller and the
majority, including those aligned with domain bounda-
ries, was in phase 0 (Figures 2, 3, 4, 5, 8).
In situ hybridization
Previous in situ hybridization and Northern studies have
shown that the four R2B family members are expressed in
many tissues throughout development: PTPκ mRNA was
Genomic organization of the murine RPTP R2B genes Figure 6
Genomic organization of the murine RPTP R2B genes. Exons are shown as vertical bars and introns as thin horizontal 
lines drawn to different scales (indicated by scale bars). The size of the genomic regions encoding the extracellular and intrac-
ellular segments of each gene is not drawn proportionally. Note that exon distribution and clustering is similar for each gene.
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present in brain, lung, skeletal muscle, heart, placenta,
liver, kidney, and intestine; PTPµ was present in brain,
lung, skeletal muscle, heart, placenta, and embryonic
blood vessels [20,21], and PCP-2 was detected in the
brain, lung, skeletal muscle, heart, kidney and placenta
[20,22,23]. The distribution of PTPρ is somewhat
anomalous in that it was almost entirely restricted to the
brain and spinal cord [9,10].
In the present study, digoxigenin–labeled cRNA probes
were used to determine the cellular localization of R2B
transcripts in specific regions of the adult (P180) mouse
brain: The olfactory bulb, cerebral cortex, hippocampus
and cerebellum (Figure 9). Each of the four R2B tran-
scripts was expressed at moderate to high levels in the
mitral, external granule and glomerular layers of the olfac-
tory bulb, and at lower levels in the external plexiform
layer. All four R2B transcripts were distributed throughout
the cerebral cortex, with the highest levels observed in lay-
ers II, IV, and V (PTPρ), IV and V (PTPµ), II to V (PTPκ),
and II through VI (PCP-2). Within the hippocampus and
dentate gyrus, large cells (Golgi II neurons) scattered
throughout the hippocampal CA1, CA2, and CA3 regions,
oriens and pyramidal layers, the hilus and subiculum,
expressed PTPρ and PTPµ at very high levels. The PTPκ
and PCP-2 transcripts were also present in Golgi II neu-
rons, however, expression was restricted to cells in the
hilus (PTPκ, PCP-2) and subiculum (PCP-2). Much
higher expression levels were present in hippocampal
pyramidal cells and dentate granule cells. Each of the four
R2B transcripts was differentially expressed in the cerebel-
lum. PTPρ mRNA was almost entirely restricted to the
granule cell layer of lobules 1–6 of the cerebellar cortex
and deep cerebellar neurons; very sparse labeling was also
present in basket and stellate cells in the molecular layer.
PTPµ was expressed at high levels in the Purkinje cells,
and at much lower levels in Golgi, stellate and basket
cells. The PTPκ transcript was present at low levels in
basket, stellate, Golgi and granule cells throughout the
cerebellar molecular and granule cell layers. PCP-2 was
expressed at moderate levels in granule and Purkinje cells,
and at lower levels in basket and stellate cells, and in deep
Pairwise percentage nucleotide identity of individual exons Figure 7
Pairwise percentage nucleotide identity of individual exons. Exons 2–31 of the four murine R2B genes were compared 
in a pairwise fashion. Exon numbers are listed on the x axis, and the corresponding percentage identity for that exon is shown 
on the y axis. Three distinct regions may be discerned: The extracellular (exons 2–13), juxtamembrane (exons 14–18) and 
phosphatase (exons 19–32) domains.
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cerebellar neurons. The sense signal for each of the four
genes (not shown) was very low and distributed uni-
formly across sections, indicating that non-specific
expression was negligible. These studies show that each of
the four R2B transcripts exhibit exclusive, as well as over-
lapping, distribution patterns.
Phylogenetic analysis of murine RPTP R2B cDNA 
sequences
The phylogenetic relationship of the entire sequence of
the R2B phosphatases encompassing both extra- and
intracellular regions was compared. Analysis of the full-
length mouse cDNA nucleotide and predicted amino acid
sequences indicated that the four genes originated from a
common ancestor that gave rise to two separate branches
(Figure 10). Of the four R2B genes, PTPρ (ptprt) and PTPµ
(ptprm) were most closely related, followed by PTPκ
(ptprk). The most distant member was PCP-2 (ptprl). Pre-
vious phylogenetic analyses, based solely on the compar-
ison of the first [3,24] and second [25] phosphatase
domains, provided similar results. A priori, the four type
R2B phosphatases could have arisen either by a single
fusion event followed by at least two rounds of duplica-
tion, or by several separate fusion events. In the first
instance, the phylogenetic tree generated by comparing
the first phosphatase domains should be the same as that
generated by comparing the entire proteins. Different
phylogenetic trees would be expected if the four R2B
phosphatases were generated by separate fusion events.
Our finding that the phylogenetic relationship of the four
Exon sizes within the murine R2B extracellular and juxtamembrane domains Figure 8
Exon sizes within the murine R2B extracellular and juxtamembrane domains. Boxed numbers indicate the number 
of nucleotides in each exon; interconnecting horizontal lines represent introns (neither are to scale). The numbers between 
exons indicate intron phases. Note the variation in exon utilization in the trans (tm) -and juxtamembrane (jm) region.
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complete proteins is the same as that of the phosphatase
domains argues in favor of the former explanation, and
supports the contention that during the transition from
single-celled to multicellular organisms, double domain
phosphatases originated by duplication, followed by
fusion to cell adhesion-like genes [25].
Transcription Factor Binding sites
Regions upstream from the transcriptional start site are
likely to be involved in the regulation of gene expression.
Although the overall cDNA sequences of the four R2B
RPTPs were quite similar, the 5' UTRs varied significantly
in sequence and length. Predicted transcription factor
binding sites included both unique and common motifs
(Table 1). Putative binding sites unique to each of the R2B
phosphatases included AP-1, HSF1, TST-1 and YY1
(PTPκ); delta EF-1, E4BP4, freac-3 and p53 sites (PTPµ);
AP-2, c-Myb, NF-1, sox-5, and Sp-1 sites (PTPρ), and freac-
7, HFH-8, HNF-3beta and N-Myc sites (PCP-2). Sites com-
mon to all four R2B genes included Oct-1, CdxA, C/EBP,
En-1, GATA-1, GATA-2, GKLF, HoxA3, Ik-2, Msx-1, Pax-4
and SRY. The greatest number of binding motifs (6–20)
was for CdxA, a homeobox-containing gene whose expres-
sion demarcates embryonic anterior-posterior boundaries
Type R2B gene expression in the adult mouse brain Figure 9
Type R2B gene expression in the adult mouse brain. In situ hybridization using digoxigenin-labeled riboprobes was used 
to localize the four R2B phosphatases in sagittal sections of a P180 male C57BL/6 mouse brain. PTPρ  (A-E), PTPµ (F-J), PTPκ 
(K-O), and PCP-2 (P-T) transcripts were present in various regions of the CNS including the olfactory bulb, cortex, hippocam-
pus, and cerebellum. Olfactory bulb: ac, anterior commissure; g, granule layer; m, mitral cell layer; gl, glomerular layer; epl, exter-
nal plexiform layer. Cortex: cortical layers I-VI. Hippocampus: d, dentate gyrus; h, hilus; or, oriens layer; py, pyramidal layer; r, 
radiatum layer; GII, Golgi II neurons. Cerebellum: dcn, deep cerebellar nuclei; ml, molecular layer; P, Purkinje cell layer; g, gran-
ule cell layer; G, Golgi cells. Arrowhead (D) shows anterior-posterior cerebellar boundary. Scale bars: Columns 1, 2 and 3 = 50 
µm; column 4 = 500 µm; column 5 = 100 µm.
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[26]. Also occurring at high frequency were SRY (3–10),
C/EBP (3–7), AML-1a (4–7) and HoxA3 (5–8) motifs.
Each of the R2B genes also had multiple transcription
factor binding sites for engrailed-1, which is active in
specific cell types of the developing central nervous sys-
tem [27]. All four genes had at least one Pax-4 binding
motif; these sites are activated in the pancreas [28],
coinciding with our observation [29] that all four R2B
genes are expressed in the MIN-6 cell line, which is
derived from pancreatic β cells. The PTPκ and PTPρ puta-
tive promoter regions also had a Pax-2 binding motif; Pax-
2 directs expression in the developing kidney [30], a doc-
umented feature of PTPκ expression in the developing
mouse [20]. Many of these predicted transcription factor-
binding sites have important roles in the developing cen-
tral nervous system, where R2B transcripts have both over-
lapping and distinctly different distributions. The
diversity seen in the promoters of the four genes, which
otherwise share high nucleotide and even higher amino
acid identity, could contribute to their unique patterns of
expression.
Alternative splicing of PTPµ, PTPκ, PTPρ, PCP-2 genes
In our analysis of R2B genomic structure, exons in the jux-
tamembrane region exhibited the greatest variability in
Murine R2B phylogenetic relationships Figure 10
Murine R2B phylogenetic relationships. Parsimony tree 
constructed from full-length sequences of mouse R2B 
cDNAs. PTPρ and PTPµ are most closely related.
ptprm
ptprt
ptprk
ptprl
DLAR
PTP1
Table 1: Predicted transcription factor binding sites in the 5' 
promoter regions of four R2B phosphatases.
Transcription factor
binding sites
PTPρ PTPµ PTPκ PCP-2
AML-1a 4 5 0 7
AP-1 0 0 1 0
AP-2 1 0 0 0
AP-4 2 0 1 0
C/EBP 6 4 3 7
C/EBPalpha 0 1 0 1
CdxA 9 6 12 20
c-Ets-1(p54) 2 1 3 0
c-Myb 1 0 0 0
c-Myc/Max 1 0 1 0
DeltaEF-1 0 1 0 0
E4BP4 0 1 0 0
En-1 2 7 3 5
Freac-3 0 1 0 0
Freac-7 0 0 0 2
GATA-1 3 2 1 3
GATA-2 1 1 1 1
GATA-3 0 2 2 0
GKLF 2 2 1 1
GR 1 1 0 0
HFH-8 0 0 0 1
HNF-3beta 0 0 0 1
HOXA3 5 7 8 7
HSF1 0 0 1 0
HSF2 1 0 1 1
Ik-2 1 4 1 2
Lmo2 complex 1 1 0 0
Msx-1 6 1 1 4
Myb 0 2 1 0
MZF1 3 1 1 0
NF-1 2 0 0 0
NF-AT 0 0 1 4
Nkx2.5 0 2 1 4
N-Myc 0 0 0 1
Oct-1 3 2 5 1
p300 1 2 0 0
p53 0 1 0 0
Pax-2 1 0 1 0
Pax-4 5 1 1 1
Pbx-1 0 1 2 3
Sox-5 1 0 0 0
Sp1 2 0 0 0
SRY 3 6 10 9
TCF11 1 2 0 0
TST-1 0 0 1 0
USF 2 0 0 1
YY1 0 0 2 0BMC Genomics 2004, 5 http://www.biomedcentral.com/1471-2164/5/14
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sequence identity, suggesting important functional
differences among the four R2B phosphatases. A
combination of phase information from individual
human and murine R2B genomic structures and extensive
Clustal X alignment of full-length cDNA sequences from
Genbank (including PTPρ sequences from this labora-
tory) was used to predict the presence of alternatively
spliced exons. Comparison of the four R2B sequences
revealed at least 8 exons that were potentially alternatively
spliced. Splicing was examined in neonatal and adult
C57BL/6 mouse brain (cortex, forebrain, brainstem, and
cerebellum) and in human fetal brain using RT-PCR. PCR
primers were designed to amplify regions encapsulating
exons 7, 8, 14, 16 and 17/18 (17a), 20/21(20a), 22/23
(22a), and 28/29 (28a) for each of the four genes. The
four R2B genes shared a common "core" of 30 exons.
Exon numbers were based on those described for PTPρ
[8]. PCR experiments showed that five of the eight tested
exons (14, 16, 17a, 20a, and 22a) were alternatively
spliced. Exons 7 and 8 were present and exon 28a was
absent in all R2B transcripts tested. All but one of the alter-
natively spliced exons (14) was located in the R2B intrac-
ellular segment. Exon 14 preceded the transmembrane
region; exons 16 and 17a encoded intracellular juxtam-
embrane sequences, and the last two exons (20a, and 22a)
encoded portions of the catalytically active, first phos-
phatase domain.
Each of the four R2B genes expressed in the brain used the
five alternatively spliced exons in a different combination:
In PTPρ transcripts, exon 17a and 20a were absent, and
exons 14, 16, and 22a were alternatively spliced (Figure
11). In PTPµ transcripts, exons 14, 16, 20a and 22a were
absent; exon 17a was present and not alternatively
spliced. The alternative use of two 5' splice consensus sites
resulted in the transcription of an additional 58 bp of the
intron between exons 13 and 15 (Figure 12). In PTPκ
mRNA, exons 14 and 22a were absent, and exons 16, 17a
and 20a were alternatively spliced (Figure 13). In PCP-2
mRNA, exons 14 was absent, exon 16 was not transcribed
in brain, and exons 17a, 20a, and 22a were alternatively
spliced (Figure 14). These results are summarized in Table
2. Splicing was also examined in human R2B transcripts
where the use of alternatively spliced exons was virtually
identical to that observed in the mouse genes. No age-
related or regional differences were observed in the CNS
in any of the above studies.
The high frequency of alternatively spliced exons in the
R2B juxtamembrane segment suggests that the region has
highly specialized functions. The importance of
alternatively spliced exons has been well documented for
the closely related Type 2 RPTP, LAR, in which a small (27
bp) alternatively spliced exon (LASE-c) was identified in
the fifth FN-III domain [31]. Subsequently, a 33 bp exon
(LASE-a), was identified in the intracellular
juxtamembrane region [32]. LASE-a, which was shown to
be brain specific and developmentally regulated, was
present in cell bodies of cultured granule cells, but was
absent in neurites. Conversely, the LASE-c isoform was
absent in cell bodies and present in neurites. Using in vitro
ligand binding assays, the laminin-nidogen extracellular
matrix complex was identified as a ligand for LAR, specif-
ically interacting with the fifth FN-III domain [33]. When
LAR bound the laminin-nidogen complex, cells formed
long processes. Inclusion of the alternatively spliced 27 bp
LASE-c exon disrupted this binding, causing changes in
cell morphology. These studies imply a role for alterna-
tively spliced exons in neurite extension through modifi-
cation of cell adhesion.
The juxtamembrane region of the four R2B phosphatases
shows greater variation in exon size and number, and is
considerably longer, than the comparable region in other
receptor-like PTPs. Furthermore, the region displays
sequence similarity to the intracellular domain of cadher-
ins, a family of calcium-dependent transmembrane
proteins involved in homophilic cell adhesion. Cadherins
bind catenins [34], which in turn bind the actin cytoskel-
eton [35] thereby influencing cell adhesiveness and
changes in morphological attributes such as neurite exten-
sion and growth cone rearrangement. The intracellular
domain is highly conserved among cadherin family
members, and is essential for cadherin-mediated cell
adhesion [36]. Both PTPµ [37] and PTPκ  [38] have been
shown to stimulate neurite extension in retinal explants
and in cerebellar cultures, respectively. Furthermore, the
intracellular segment of PTPµ binds directly to the intrac-
ellular domain of E-cadherin [39,40] in a complex with α-
and  β-catenin. The other R2B phosphatases have also
been shown to interact with the cadherin/catenin path-
way: PTPκ interacts with β- and γ-catenin at adherens
junctions [41]; PCP-2 colocalizes with β-catenin and E-
cadherin at cell junctions [22], and directly interacts with
β-catenin [42]; and PTPρ binds cytoskeletal components
including  α-actinin and β-catenin [29]. More recent
studies on PTPµ have further delineated this pathway:
PTPµ-mediated neurite extension in retinal neurons is
also dependent on PKCδ [43] and Cdc42 [44] activity. In
addition, PTPµ is required for E-cadherin dependent cell
adhesion [45], and for recruiting RACK1 to cell-cell con-
tacts [46]. The physical association of PTPµ with RACK1
has been demonstrated [46]. It is likely that the juxtam-
embrane segment also mediates the interaction of PTPµ
with these additional transduction molecules. The pre-
ponderance of alternatively spliced exons in the juxtam-
embrane region may add specificity to R2B adhesive
functions via regulation of juxtamembrane binding
specificity.BMC Genomics 2004, 5 http://www.biomedcentral.com/1471-2164/5/14
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Conclusions
Analysis of the intron/exon structure of the four R2B
phosphatase genes revealed that despite considerable dis-
parities in gene size, genomic organization was virtually
identical, possibly reflecting their close phylogenetic
relationship. In the central nervous system, the expres-
sions of the four transcripts were unique, perhaps result-
ing from the use of different transcription binding sites.
Considerable variation in exon utilization was seen in the
juxtamembrane domain, a region shown to interact with
a variety of intracellular signal transduction molecules.
Alternative splicing of exons in this region could result in
different functional roles for each of the R2B
phosphatases.
Methods
Genomic structure of R2B genes
The genomic structure of the four murine R2B RPTP genes
was determined as follows: The R2B cDNA sequences
were used to identify the corresponding genomic shotgun
clones in the Celera mouse genomic DNA database, using
BLAST (parameters set to default values) and MEGABLAST
programs. The identified individual shotgun fragments
were aligned onto their respective scaffolds, and distances
were calculated based on scaffold lengths. A similar
approach using the NCBI [47] and Sanger Center [48]
databases was used to identify the human R2B gene struc-
ture. The identified clones were superimposed onto the
assembled minimal tiling paths and the size of the genes
Alternative splicing of PTPρ mRNA Figure 11
Alternative splicing of PTPρ mRNA. RT-PCR products were amplified using primers flanking exon 14 (panels A and B), 
exon 16 (panels C and D) and exon 22a (panels E and F). Left panels: bands in lanes 1, 2, and 3 are from human fetal brain, 
mouse P1 brain, and mouse P60 brain total RNA, respectively. Right panels: bands in lanes 4, 5, 6 and 7 contain total RNA from 
cerebellum, brain stem, basal forebrain and cortex (P23), respectively. Transcripts containing both splice forms of exons 14, 16 
and 22a were found in all lanes.BMC Genomics 2004, 5 http://www.biomedcentral.com/1471-2164/5/14
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was calculated from the sizes of the individual
overlapping clones. In order to determine exon/intron
organization, each cDNA sequence was compared to
genomic DNA sequences using Spidey [49]. The vertebrate
genomic sequence was selected as input, "use large intron
sizes" was enabled, and the minimum mRNA-genomic
identity was set to 60%.
Phylogenetic analysis
RPTP R2B nucleotide and amino acid sequences were
aligned using Vector NTI Suite, V.6, AlignX. PAUP 4.0b10
was used to construct a phylogenetic tree of the R2B gene
family. The S. cerevisiae tyrosine phosphatase PTP1, and
the D. melanogaster receptor tyrosine phosphatase, DLAR,
were used as outgroups. Rooted phylogenetic trees were
drawn using the parsimony method with transversions
weighted 10:1 over transitions, and changes in the first
nucleotide of the triplet codon were weighted by a factor
of 2 over changes in the second or third nucleotides.
Heuristic searches were used to find the optimum tree,
with the order of sequence additions randomized.
Transcription factor binding sites
The genomic region to be examined for transcription fac-
tor binding sites was determined using BLAST2 [50] and
FirstEF [51]. The RPTP 5' UTRs and genomic DNA
sequences were aligned pairwise to detect introns. For
cases where multiple 5' UTRs were reported in Genbank,
the sequences were aligned and differences identified as
either an incomplete reporting of the 5' UTR, or possible
alternative start sites if sequences were located in different
regions of the genome. The "MATCH" program [52] was
used to identify potential transcription factor binding
sites in the 5000 bp preceding the 5' UTR, using the Verte-
brate matrix of the TRANSFAC 5.0 database, with cut off
values set to "minimize false positives and false
negatives".
Riboprobe synthesis and in situ hybridization
The distribution of R2B RPTPs in the brain was deter-
mined by in situ hybridization with digoxigenin-labeled
RNA probes, synthesized as follows: The design of RT-PCR
and PCR primers was based on the reported sequences
(Genbank) for murine PTPρ (NM_021464), PTPµ
(NM_008984), PTPκ (NM_008983), and PCP-2
(NM_011214). RT-PCR primers spanned a region near
the 3' end of the second phosphatase domain, and PCR
primers were designed to amplify the region correspond-
ing to the first and second phosphatase domains of PTPρ,
PTPµ, and PTPκ, and the second domain of PCP-2. The
expected sizes for PTPρ (1.72 kb), PTPµ (1.5 Kb), PTPκ
(1.5 Kb), and PCP-2 (465 bp) were obtained and cloned
into the pBLUEscript II KS vector. Probes were labeled
with digoxigenin using the DIG RNA Labeling Kit (Roche
#1175025) as described by the manufacturer with the fol-
lowing modifications. In the labeling mix, 0.5 µl of 40 U/
µl RNase OUT (Life Technologies), and 2 µl of 20 U/µl T7
(antisense) or T3 (sense) RNA polymerase (Roche), was
added. The DNA template was digested with 1 U/µl
RNase-free DNase I (Epicentre). Transcripts were purified
by standard RNA precipitation, and the pellets resus-
pended in 50 µl DEPC-treated H20. Adult (P60) C57BL/6
mouse brains were cryostat sectioned (20 µm) in the sag-
ittal plane, and in situ hybridization was conducted as
described previously [9,10]. Riboprobe-labeled sections
were washed at a final stringency of 0.125x SSC, at 65°C.
Following the hybridization washes, the sections were
processed with an anti-digoxigenin antibody (Roche)
[53], dried and coverslipped.
Alternative splicing of the four RPTP R2B genes
First strand cDNA was made from total RNA from neona-
tal (P1) and adult (P60) mouse whole brain using Super-
script II Reverse Transcriptase (Invitrogen). In addition,
cDNA was made from cerebellum, brainstem, forebrain
and cortex of a P23 mouse, and a 16–24 week old human
fetal brain (Clontech). The reverse primer (5' CACG-
CACACAGTTGAAGATGTCC), which was used in all RPTP
first strand cDNA synthesis, is complementary to a region
near the end of the first phosphatase domain (3580 to
3602 nt; NM_007050). PCR was performed (Platinum
Taq, Invitrogen) as recommended by the manufacturer.
Alternative splicing of PTPµ mRNA Figure 12
Alternative splicing of PTPµ mRNA. RT-PCR products 
were amplified using primers flanking exon 14. Panel A: 
Bands in lanes 1, 2, and 3 are from human fetal brain, mouse 
P1 brain, and mouse P60 brain total RNA, respectively. Panel 
B: Bands in lanes 4, 5, 6 and 7 contain total RNA from P23 
cerebellum, brain stem, basal forebrain and cortex, respec-
tively. Transcripts containing both splice forms were found in 
all lanes.BMC Genomics 2004, 5 http://www.biomedcentral.com/1471-2164/5/14
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All primers were used at a final concentration of 250 nM.
An Eppendorf Mastercycler Gradient was used with the
following cycling parameters: 2 minutes at 94°C, 35
cycles of 15 seconds at 94°C, 30 seconds at 58 or 60°C,
45 seconds at 72°C, and a final extension step (5 minutes
at 72°C). The PCR products were run on 3.5% NuSieve
GTG agarose (Biowhittaker) gels, stained with ethidium
bromide and photographed using a Kodak DC120
camera. DNA bands were isolated and gel purified using
Qiagen Gel Extraction kit. Identity of all RT-PCR products
was confirmed by sequencing. Primer sequences are avail-
able from the authors upon request (rotter.1@osu.edu).
List of Abbreviations
AS, alternatively spliced; bp, base pairs; DEPC, diethyl
pyrocarbonate; Ig, immunoglobulin-like domain; EST,
expressed sequence tags; FN-III, fibronectin type III repeat;
MAM, meprin/A5/µ domain; nt, nucleotide; PCR,
polymerase chain reaction; RT-PCR, reverse transcriptase
polymerase chain reaction; RPTP, receptor-like protein
tyrosine phosphatase; TM, transmembrane domain; UTR,
untranslated region. Genbank accession numbers for
sequences used: yeast PTP1 Z74278; yeast PTP2 Z75116;
mouse ptprt (PTPρ) NM_021464; human PTPRT (PTPρ)
NM_007050; mouse ptprl (PCP-2) NM_011214; human
PTPRU (PCP-2) NM_005704; mouse ptprm  (PTPµ)
Alternative splicing of PTPκ mRNA Figure 13
Alternative splicing of PTPκ mRNA. RT-PCR products were amplified using primers flanking exon 16 (panels A and B), 
exon 17a (panels C and D) and exon 20a (panels E and F). Left panels: bands in lanes 1, 2, and 3 are from human fetal brain, 
mouse P1 brain, and mouse P60 brain total RNA, respectively. Right panels: bands in lanes 4, 5, 6 and 7 contain total RNA from 
cerebellum, brain stem, basal forebrain and cortex (P23), respectively. Transcripts containing both splice forms of exons 16 and 
20a were found in all lanes.
17a
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Alternative splicing of PCP-2 mRNA Figure 14
Alternative splicing of PCP-2 mRNA. RT-PCR products were amplified using primers flanking exon 17a (panels A and B), 
exon 20a (panels C and D) and exon 22a (panels E and F). Left panels: bands in lanes 1, 2, and 3 are from human fetal brain, 
mouse P1 brain, and mouse P60 brain total RNA, respectively. Right panels: bands in lanes 4, 5, 6 and 7 contain total RNA from 
cerebellum, brain stem, basal forebrain and cortex (P23), respectively. Transcripts containing both splice forms of exons 17a, 
20a, and 22a were found in all lanes.
Table 2: Summary of exon usage in R2B juxtamembrane and phosphatase domains.
Exon # PTPρ PTPµ PTPκ PCP-2
7 1111
8 1111
14 2000
16 202 1 * *
17a 0122
20a 0022
22a 2002
28a 0000
Eight genomic regions containing predicted exons were examined. 0 indicates that the exon was absent (one band at the smallest expected size); 1 
indicates the exon was present, but not alternatively spliced (one band seen at the largest expected size); 2 indicates that the exon was present and 
alternatively spliced (2 bands observed). ** exon not transcribed in brain.
17a
20a
22aBMC Genomics 2004, 5 http://www.biomedcentral.com/1471-2164/5/14
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NM_008984; human PTPRM (PTPµ) NM_002845;
mouse ptprk (PTPκ) NM_008983; human PTPRK (PTPκ)
NM_002844.
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